U.S. Pharmaceuticals & Biotech Profitable Climbers

Alnylam Pharmaceuticals

Market Cap: US$52.9b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Zevra Therapeutics

Market Cap: US$469.5m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Corcept Therapeutics

Market Cap: US$4.0b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Alvotech

Market Cap: US$1.6b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Kiniksa Pharmaceuticals International

Market Cap: US$3.2b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Emergent BioSolutions

Market Cap: US$657.0m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

SIGA Technologies

Market Cap: US$449.0m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

XOMA Royalty

Market Cap: US$346.6m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

BeOne Medicines

Market Cap: US$34.4b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Krystal Biotech

Market Cap: US$7.2b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Eli Lilly

Market Cap: US$967.3b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Earth Science Tech

Market Cap: US$37.9m

Together with its subsidies, focuses on health and wellness industry.

Gyre Therapeutics

Market Cap: US$619.0m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

Protagonist Therapeutics

Market Cap: US$5.5b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Abeona Therapeutics

Market Cap: US$287.8m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

TG Therapeutics

Market Cap: US$4.3b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

ADMA Biologics

Market Cap: US$4.3b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Niagen Bioscience

Market Cap: US$500.6m

Operates as a bioscience company engages in developing healthy aging products.

AbbVie

Market Cap: US$405.3b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Phibro Animal Health

Market Cap: US$1.5b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Vericel

Market Cap: US$1.8b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Repligen

Market Cap: US$9.3b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Harmony Biosciences Holdings

Market Cap: US$2.2b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

ANI Pharmaceuticals

Market Cap: US$1.6b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Ligand Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Indivior

Market Cap: US$4.5b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

MannKind

Market Cap: US$1.7b

A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.

Sotera Health

Market Cap: US$5.0b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Amneal Pharmaceuticals

Market Cap: US$4.0b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.